Natus Medical (BABY) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Roth Capital Raises Price Target Following Natus Medical's (BABY) 3Q Results
October 22, 2015 8:20 AM EDTRoth Capital reiterated a Buy rating on Natus Medical (NASDAQ: BABY), and raised the price target to $53.00 (from $51.00), following the company's 3Q15 earnings results. BABY continues to outperform expectations, with 3Q non-GAAP operating margin of 19.9%.
Analyst Chris Lewis commented, "We remain bullish on BABY... More
